Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
曲妥珠单抗和帕妥珠单抗联合放化疗治疗可切除的人表皮生长因子受体2阳性食管腺癌的II期可行性和生物标志物研究:TRAP研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.19.01814
Stroes, Charlotte I; Schokker, Sandor; Creemers, Aafke; Molenaar, Remco J; Hulshof, Maarten C C M; van der Woude, Stephanie O; Bennink, Roel J; Mathôt, Ron A A; Krishnadath, Kausilia K; Punt, Cornelis J A; Verhoeven, Rob H A; van Oijen, Martijn G H; Creemers, Geert-Jan; Nieuwenhuijzen, Grard A P; van der Sangen, Maurice J C; Beerepoot, Laurens V; Heisterkamp, Joos; Los, Maartje; Slingerland, Marije; Cats, Annemieke; Hospers, Geke A P; Bijlsma, Maarten F; van Berge Henegouwen, Mark I; Meijer, Sybren L; van Laarhoven, Hanneke W M